Login Register Cart 0
Generic placeholder image

Cardiovascular & Hematological Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5257
ISSN (Online): 1875-6182

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Genetic Underpinnings of Pulmonary Fibrosis: An Overview

Author(s): Sushweta Mahalanobish, Sumit Ghosh and Parames C. Sil*

Volume 22, Issue 3, 2024

Published on: 26 January, 2024

Page: [367 - 374] Pages: 8

DOI: 10.2174/0118715257261006231207113809

Price: $65

Abstract

Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disorder, in which genetic and environmental factors are involved in disease onset. Although, by definition, the disease is considered idiopathic in nature, evidence-based studies have indicated familial cases of pulmonary fibrosis, in which genetic factors contribute to IPF pathogenesis.

Methods: Both common as well as rare genetic variants are associated with sporadic as well as familial forms of IPF. Although clinical inferences of the genetic association have still not been explored properly, observation-based studies have found a genotypic influence on disease development and outcome.

Results: Based on genetic studies, individuals with a risk of IPF can be easily identified and can be classified more precisely. Identification of genetic variants also helps to develop more effective therapeutic approaches.

Conclusion: Further comprehensive research is needed to get a blueprint of IPF pathogenesis. The rapidly evolving field of genetic engineering and molecular biology, along with the bioinformatics approach, will possibly explore a new horizon very soon to achieve this goal.

« Previous Next »
[1]
Spagnolo, P.; Cottin, V. Genetics of idiopathic pulmonary fibrosis: From mechanistic pathways to personalised medicine. J. Med. Genet., 2017, 54(2), 93-99.
[http://dx.doi.org/10.1136/jmedgenet-2016-103973] [PMID: 28011761]
[2]
Mahalanobish, S.; Saha, S.; Dutta, S.; Sil, P.C. Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis. Pharmacol. Res., 2020, 152, 104591.
[http://dx.doi.org/10.1016/j.phrs.2019.104591] [PMID: 31837390]
[3]
Lee, S.; Islam, M.N.; Boostanpour, K.; Aran, D.; Jin, G.; Christenson, S.; Matthay, M.A.; Eckalbar, W.L.; DePianto, D.J.; Arron, J.R.; Magee, L.; Bhattacharya, S.; Matsumoto, R.; Kubota, M.; Farber, D.L.; Bhattacharya, J.; Wolters, P.J.; Bhattacharya, M. Molecular programs of fibrotic change in aging human lung. Nat. Commun., 2021, 12(1), 6309.
[http://dx.doi.org/10.1038/s41467-021-26603-2] [PMID: 34728633]
[4]
George, P.M.; Patterson, C.M.; Reed, A.K.; Thillai, M. Lung transplantation for idiopathic pulmonary fibrosis. Lancet Respir. Med., 2019, 7(3), 271-282.
[http://dx.doi.org/10.1016/S2213-2600(18)30502-2] [PMID: 30738856]
[5]
Pardo, A.; Selman, M. The interplay of the genetic architecture, aging, and environmental factors in the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol., 2021, 64(2), 163-172.
[http://dx.doi.org/10.1165/rcmb.2020-0373PS] [PMID: 32946290]
[6]
Mathai, S.K.; Schwartz, D.A.; Warg, L.A. Genetic susceptibility and pulmonary fibrosis. Curr. Opin. Pulm. Med., 2014, 20(5), 429-435.
[http://dx.doi.org/10.1097/MCP.0000000000000074] [PMID: 25022318]
[7]
Davison, L.M. Neurofibromatosis with diffuse interstitial pulmonary fibrosis and phaeochromocytoma. Br. J. Radiol., 1967, 40(475), 549-551.
[http://dx.doi.org/10.1259/0007-1285-40-475-549] [PMID: 4961404]
[8]
Depinho, R.A.; Kaplan, K.L. The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations. Medicine, 1985, 64(3), 192-202.
[http://dx.doi.org/10.1097/00005792-198505000-00004] [PMID: 3921802]
[9]
Riccardi, V.M. Von recklinghausen neurofibromatosis. N. Engl. J. Med., 1981, 305(27), 1617-1627.
[http://dx.doi.org/10.1056/NEJM198112313052704] [PMID: 6796886]
[10]
Malik, S.K.; Pardee, N.; Martin, C.J. Involvement of the lungs in tuberous sclerosis. Chest, 1970, 58(5), 538-540.
[http://dx.doi.org/10.1378/chest.58.5.538] [PMID: 5507952]
[11]
Borie, R.; Crestani, B.; Guyard, A.; Lidove, O. Interstitial lung disease in lysosomal storage disorders. Eur. Respir. Rev., 2021, 30(160), 200363.
[http://dx.doi.org/10.1183/16000617.0363-2020] [PMID: 33927007]
[12]
Kropski, J.A.; Blackwell, T.S.; Loyd, J.E. The genetic basis of idiopathic pulmonary fibrosis. Eur. Respir. J., 2015, 45(6), 1717-1727.
[http://dx.doi.org/10.1183/09031936.00163814] [PMID: 25837031]
[13]
Spagnolo, P.; Grunewald, J.; du Bois, R.M. Genetic determinants of pulmonary fibrosis: Evolving concepts. Lancet Respir. Med., 2014, 2(5), 416-428.
[http://dx.doi.org/10.1016/S2213-2600(14)70047-5] [PMID: 24815806]
[14]
Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann. Intern. Med., 2009, 151(4), W.
[http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00136] [PMID: 19622512]
[15]
Krauss, E.; Gehrken, G.; Drakopanagiotakis, F.; Tello, S.; Dartsch, R.C.; Maurer, O.; Windhorst, A.; von der Beck, D.; Griese, M.; Seeger, W.; Guenther, A. Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF). BMC Pulm. Med., 2019, 19(1), 130.
[http://dx.doi.org/10.1186/s12890-019-0895-6] [PMID: 31319833]
[16]
Steele, M.P.; Speer, M.C.; Loyd, J.E.; Brown, K.K.; Herron, A.; Slifer, S.H.; Burch, L.H.; Wahidi, M.M.; Phillips, J.A., III; Sporn, T.A.; McAdams, H.P.; Schwarz, M.I.; Schwartz, D.A. Clinical and pathologic features of familial interstitial pneumonia. Am. J. Respir. Crit. Care Med., 2005, 172(9), 1146-1152.
[http://dx.doi.org/10.1164/rccm.200408-1104OC] [PMID: 16109978]
[17]
Bellou, V.; Belbasis, L.; Evangelou, E. Tobacco smoking and risk for pulmonary fibrosis: A prospective cohort study from the UK Biobank. Chest, 2021, 160(3), 983-993.
[http://dx.doi.org/10.1016/j.chest.2021.04.035] [PMID: 33905677]
[18]
Ballester, B.; Milara, J.; Cortijo, J. Mucins as a new frontier in pulmonary fibrosis. J. Clin. Med., 2019, 8(9), 1447.
[http://dx.doi.org/10.3390/jcm8091447] [PMID: 31514468]
[19]
Seibold, M.A.; Wise, A.L.; Speer, M.C.; Steele, M.P.; Brown, K.K.; Loyd, J.E.; Fingerlin, T.E.; Zhang, W.; Gudmundsson, G.; Groshong, S.D.; Evans, C.M.; Garantziotis, S.; Adler, K.B.; Dickey, B.F.; du Bois, R.M.; Yang, I.V.; Herron, A.; Kervitsky, D.; Talbert, J.L.; Markin, C.; Park, J.; Crews, A.L.; Slifer, S.H.; Auerbach, S.; Roy, M.G.; Lin, J.; Hennessy, C.E.; Schwarz, M.I.; Schwartz, D.A. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med., 2011, 364(16), 1503-1512.
[http://dx.doi.org/10.1056/NEJMoa1013660] [PMID: 21506741]
[20]
Seibold, M.A.; Smith, R.W.; Urbanek, C.; Groshong, S.D.; Cosgrove, G.P.; Brown, K.K.; Schwarz, M.I.; Schwartz, D.A.; Reynolds, S.D. The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. PLoS One, 2013, 8(3), e58658.
[http://dx.doi.org/10.1371/journal.pone.0058658] [PMID: 23527003]
[21]
Roy, M.G.; Livraghi-Butrico, A.; Fletcher, A.A.; McElwee, M.M.; Evans, S.E.; Boerner, R.M.; Alexander, S.N.; Bellinghausen, L.K.; Song, A.S.; Petrova, Y.M.; Tuvim, M.J.; Adachi, R.; Romo, I.; Bordt, A.S.; Bowden, M.G.; Sisson, J.H.; Woodruff, P.G.; Thornton, D.J.; Rousseau, K.; De la Garza, M.M.; Moghaddam, S.J.; Karmouty-Quintana, H.; Blackburn, M.R.; Drouin, S.M.; Davis, C.W.; Terrell, K.A.; Grubb, B.R.; O’Neal, W.K.; Flores, S.C.; Cota-Gomez, A.; Lozupone, C.A.; Donnelly, J.M.; Watson, A.M.; Hennessy, C.E.; Keith, R.C.; Yang, I.V.; Barthel, L.; Henson, P.M.; Janssen, W.J.; Schwartz, D.A.; Boucher, R.C.; Dickey, B.F.; Evans, C.M. Muc5b is required for airway defence. Nature, 2014, 505(7483), 412-416.
[http://dx.doi.org/10.1038/nature12807] [PMID: 24317696]
[22]
Fingerlin, T.E.; Murphy, E.; Zhang, W.; Peljto, A.L.; Brown, K.K.; Steele, M.P.; Loyd, J.E.; Cosgrove, G.P.; Lynch, D.; Groshong, S.; Collard, H.R.; Wolters, P.J.; Bradford, W.Z.; Kossen, K.; Seiwert, S.D.; du Bois, R.M.; Garcia, C.K.; Devine, M.S.; Gudmundsson, G.; Isaksson, H.J.; Kaminski, N.; Zhang, Y.; Gibson, K.F.; Lancaster, L.H.; Cogan, J.D.; Mason, W.R.; Maher, T.M.; Molyneaux, P.L.; Wells, A.U.; Moffatt, M.F.; Selman, M.; Pardo, A.; Kim, D.S.; Crapo, J.D.; Make, B.J.; Regan, E.A.; Walek, D.S.; Daniel, J.J.; Kamatani, Y.; Zelenika, D.; Smith, K.; McKean, D.; Pedersen, B.S.; Talbert, J.; Kidd, R.N.; Markin, C.R.; Beckman, K.B.; Lathrop, M.; Schwarz, M.I.; Schwartz, D.A. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat. Genet., 2013, 45(6), 613-620.
[http://dx.doi.org/10.1038/ng.2609] [PMID: 23583980]
[23]
Carloni, A.; Poletti, V.; Fermo, L.; Bellomo, N.; Chilosi, M. Heterogeneous distribution of mechanical stress in human lung: A mathematical approach to evaluate abnormal remodeling in IPF. J. Theor. Biol., 2013, 332, 136-140.
[http://dx.doi.org/10.1016/j.jtbi.2013.04.038] [PMID: 23665208]
[24]
Mathai, S.K.; Pedersen, B.S.; Smith, K.; Russell, P.; Schwarz, M.I.; Brown, K.K.; Steele, M.P.; Loyd, J.E.; Crapo, J.D.; Silverman, E.K.; Nickerson, D.; Fingerlin, T.E.; Yang, I.V.; Schwartz, D.A. Desmoplakin variants are associated with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 2016, 193(10), 1151-1160.
[http://dx.doi.org/10.1164/rccm.201509-1863OC] [PMID: 26669357]
[25]
Königshoff, M.; Kramer, M.; Balsara, N.; Wilhelm, J.; Amarie, O.V.; Jahn, A.; Rose, F.; Fink, L.; Seeger, W.; Schaefer, L.; Günther, A.; Eickelberg, O. WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J. Clin. Invest., 2009, 119(4), 772-787.
[http://dx.doi.org/10.1172/JCI33950] [PMID: 19287097]
[26]
Allen, R.J.; Porte, J.; Braybrooke, R.; Flores, C.; Fingerlin, T.E.; Oldham, J.M.; Guillen-Guio, B.; Ma, S.F.; Okamoto, T.; John, A.E.; Obeidat, M.; Yang, I.V.; Henry, A.; Hubbard, R.B.; Navaratnam, V.; Saini, G.; Thompson, N.; Booth, H.L.; Hart, S.P.; Hill, M.R.; Hirani, N.; Maher, T.M.; McAnulty, R.J.; Millar, A.B.; Molyneaux, P.L.; Parfrey, H.; Rassl, D.M.; Whyte, M.K.B.; Fahy, W.A.; Marshall, R.P.; Oballa, E.; Bossé, Y.; Nickle, D.C.; Sin, D.D.; Timens, W.; Shrine, N.; Sayers, I.; Hall, I.P.; Noth, I.; Schwartz, D.A.; Tobin, M.D.; Wain, L.V.; Jenkins, R.G. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: A genome-wide association study. Lancet Respir. Med., 2017, 5(11), 869-880.
[http://dx.doi.org/10.1016/S2213-2600(17)30387-9] [PMID: 29066090]
[27]
Hunninghake, G.M.; Hatabu, H.; Okajima, Y.; Gao, W.; Dupuis, J.; Latourelle, J.C.; Nishino, M.; Araki, T.; Zazueta, O.E.; Kurugol, S.; Ross, J.C.; San José Estépar, R.; Murphy, E.; Steele, M.P.; Loyd, J.E.; Schwarz, M.I.; Fingerlin, T.E.; Rosas, I.O.; Washko, G.R.; O’Connor, G.T.; Schwartz, D.A. MUC5B promoter polymorphism and interstitial lung abnormalities. N. Engl. J. Med., 2013, 368(23), 2192-2200.
[http://dx.doi.org/10.1056/NEJMoa1216076] [PMID: 23692170]
[28]
Shah, J.A.; Vary, J.C.; Chau, T.T.H.; Bang, N.D.; Yen, N.T.B.; Farrar, J.J.; Dunstan, S.J.; Hawn, T.R. Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis. J. Immunol., 2012, 189(4), 1737-1746.
[http://dx.doi.org/10.4049/jimmunol.1103541] [PMID: 22778396]
[29]
O’Dwyer, D.N.; Armstrong, M.E.; Trujillo, G.; Cooke, G.; Keane, M.P.; Fallon, P.G.; Simpson, A.J.; Millar, A.B.; McGrath, E.E.; Whyte, M.K.; Hirani, N.; Hogaboam, C.M.; Donnelly, S.C. The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 2013, 188(12), 1442-1450.
[http://dx.doi.org/10.1164/rccm.201304-0760OC] [PMID: 24070541]
[30]
Kukkonen, M.K.; Vehmas, T.; Piirilä, P.; Hirvonen, A. Genes involved in innate immunity associated with asbestos-related fibrotic changes. Occup. Environ. Med., 2014, 71(1), 48-54.
[http://dx.doi.org/10.1136/oemed-2013-101555] [PMID: 24142982]
[31]
Yasutomo, K. Genetics and animal models of familial pulmonary fibrosis. Int. Immunol., 2021, 33(12), 653-657.
[http://dx.doi.org/10.1093/intimm/dxab026] [PMID: 34049386]
[32]
Barros, A.; Oldham, J.; Noth, I. Genetics of idiopathic pulmonary fibrosis. Am. J. Med. Sci., 2019, 357(5), 379-383.
[http://dx.doi.org/10.1016/j.amjms.2019.02.009] [PMID: 31010464]
[33]
McCormack, F.X.; King, T.E., Jr; Bucher, B.L.; Nielsen, L.; Mason, R.J.; McCormac, F.X. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 1995, 152(2), 751-759.
[http://dx.doi.org/10.1164/ajrccm.152.2.7633738] [PMID: 7633738]
[34]
Lawson, W.E.; Crossno, P.F.; Polosukhin, V.V.; Roldan, J.; Cheng, D.S.; Lane, K.B.; Blackwell, T.R.; Xu, C.; Markin, C.; Ware, L.B.; Miller, G.G.; Loyd, J.E.; Blackwell, T.S. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am. J. Physiol. Lung Cell. Mol. Physiol., 2008, 294(6), L1119-L1126.
[http://dx.doi.org/10.1152/ajplung.00382.2007] [PMID: 18390830]
[35]
Venosa, A.; Katzen, J.; Tomer, Y.; Kopp, M.; Jamil, S.; Russo, S.J.; Mulugeta, S.; Beers, M.F. Epithelial expression of an interstitial lung disease–associated mutation in surfactant protein-C modulates recruitment and activation of key myeloid cell populations in mice. J. Immunol., 2019, 202(9), 2760-2771.
[http://dx.doi.org/10.4049/jimmunol.1900039] [PMID: 30910861]
[36]
Goto, H.; Ledford, J.G.; Mukherjee, S.; Noble, P.W.; Williams, K.L.; Wright, J.R. The role of surfactant protein A in bleomycin-induced acute lung injury. Am. J. Respir. Crit. Care Med., 2010, 181(12), 1336-1344.
[http://dx.doi.org/10.1164/rccm.200907-1002OC] [PMID: 20167853]
[37]
Blackburn, E.H.; Epel, E.S.; Lin, J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science, 2015, 350(6265), 1193-1198.
[http://dx.doi.org/10.1126/science.aab3389] [PMID: 26785477]
[38]
Newton, C.A.; Batra, K.; Torrealba, J.; Kozlitina, J.; Glazer, C.S.; Aravena, C.; Meyer, K.; Raghu, G.; Collard, H.R.; Garcia, C.K. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur. Respir. J., 2016, 48(6), 1710-1720.
[http://dx.doi.org/10.1183/13993003.00308-2016] [PMID: 27540018]
[39]
Cronkhite, J.T.; Xing, C.; Raghu, G.; Chin, K.M.; Torres, F.; Rosenblatt, R.L.; Garcia, C.K. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 2008, 178(7), 729-737.
[http://dx.doi.org/10.1164/rccm.200804-550OC] [PMID: 18635888]
[40]
Alder, J.K.; Chen, J.J.L.; Lancaster, L.; Danoff, S.; Su, S.; Cogan, J.D.; Vulto, I.; Xie, M.; Qi, X.; Tuder, R.M.; Phillips, J.A., III; Lansdorp, P.M.; Loyd, J.E.; Armanios, M.Y. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci., 2008, 105(35), 13051-13056.
[http://dx.doi.org/10.1073/pnas.0804280105] [PMID: 18753630]
[41]
Zhang, K.; Xu, L.; Cong, Y.S. Telomere dysfunction in idiopathic pulmonary fibrosis. Front. Med., 2021, 8, 739810.
[http://dx.doi.org/10.3389/fmed.2021.739810] [PMID: 34859008]
[42]
Heiss, N.S.; Knight, S.W.; Vulliamy, T.J.; Klauck, S.M.; Wiemann, S.; Mason, P.J.; Poustka, A.; Dokal, I. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet., 1998, 19(1), 32-38.
[http://dx.doi.org/10.1038/ng0598-32] [PMID: 9590285]
[43]
Stuart, B.D.; Choi, J.; Zaidi, S.; Xing, C.; Holohan, B.; Chen, R.; Choi, M.; Dharwadkar, P.; Torres, F.; Girod, C.E.; Weissler, J.; Fitzgerald, J.; Kershaw, C.; Klesney-Tait, J.; Mageto, Y.; Shay, J.W.; Ji, W.; Bilguvar, K.; Mane, S.; Lifton, R.P.; Garcia, C.K. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat. Genet., 2015, 47(5), 512-517.
[http://dx.doi.org/10.1038/ng.3278] [PMID: 25848748]
[44]
Alder, J.K.; Stanley, S.E.; Wagner, C.L.; Hamilton, M.; Hanumanthu, V.S.; Armanios, M. Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis. Chest, 2015, 147(5), 1361-1368.
[http://dx.doi.org/10.1378/chest.14-1947] [PMID: 25539146]
[45]
Gable, D.L.; Gaysinskaya, V.; Atik, C.C.; Talbot, C.C., Jr; Kang, B.; Stanley, S.E.; Pugh, E.W.; Amat-Codina, N.; Schenk, K.M.; Arcasoy, M.O.; Brayton, C.; Florea, L.; Armanios, M. ZCCHC8, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation. Genes Dev., 2019, 33(19-20), 1381-1396.
[http://dx.doi.org/10.1101/gad.326785.119] [PMID: 31488579]
[46]
Ruggero, D.; Grisendi, S.; Piazza, F.; Rego, E.; Mari, F.; Rao, P.H.; Cordon-Cardo, C.; Pandolfi, P.P. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science, 2003, 299(5604), 259-262.
[http://dx.doi.org/10.1126/science.1079447] [PMID: 12522253]
[47]
Kropski, J.A.; Mitchell, D.B.; Markin, C.; Polosukhin, V.V.; Choi, L.; Johnson, J.E.; Lawson, W.E.; Phillips, J.A., III; Cogan, J.D.; Blackwell, T.S.; Loyd, J.E. A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia. Chest, 2014, 146(1), e1-e7.
[http://dx.doi.org/10.1378/chest.13-2224] [PMID: 24504062]
[48]
Egger, G.; Liang, G.; Aparicio, A.; Jones, P.A. Epigenetics in human disease and prospects for epigenetic therapy. Nature, 2004, 429(6990), 457-463.
[http://dx.doi.org/10.1038/nature02625] [PMID: 15164071]
[49]
Antoniou, K.M.; Tomassetti, S.; Tsitoura, E.; Vancheri, C. Idiopathic pulmonary fibrosis and lung cancer. Curr. Opin. Pulm. Med., 2015, 21(6), 626-633.
[http://dx.doi.org/10.1097/MCP.0000000000000217] [PMID: 26390339]
[50]
Selman, M.; López-Otín, C.; Pardo, A. Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis. Eur. Respir. J., 2016, 48(2), 538-552.
[http://dx.doi.org/10.1183/13993003.00398-2016] [PMID: 27390284]
[51]
Tennis, M.A.; VanScoyk, M.M.; Wilson, L.A.; Kelley, N.; Winn, R.A. Methylation of Wnt7a is modulated by DNMT1 and cigarette smoke condensate in non-small cell lung cancer. PLoS One, 2012, 7(3), e32921.
[http://dx.doi.org/10.1371/journal.pone.0032921] [PMID: 22403725]
[52]
Sanders, Y.Y.; Ambalavanan, N.; Halloran, B.; Zhang, X.; Liu, H.; Crossman, D.K.; Bray, M.; Zhang, K.; Thannickal, V.J.; Hagood, J.S. Altered DNA methylation profile in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 2012, 186(6), 525-535.
[http://dx.doi.org/10.1164/rccm.201201-0077OC] [PMID: 22700861]
[53]
Yang, I.V.; Pedersen, B.S.; Rabinovich, E.; Hennessy, C.E.; Davidson, E.J.; Murphy, E.; Guardela, B.J.; Tedrow, J.R.; Zhang, Y.; Singh, M.K.; Correll, M.; Schwarz, M.I.; Geraci, M.; Sciurba, F.C.; Quackenbush, J.; Spira, A.; Kaminski, N.; Schwartz, D.A. Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 2014, 190(11), 1263-1272.
[http://dx.doi.org/10.1164/rccm.201408-1452OC] [PMID: 25333685]
[54]
Evans, C.M.; Fingerlin, T.E.; Schwarz, M.I.; Lynch, D.; Kurche, J.; Warg, L.; Yang, I.V.; Schwartz, D.A. Idiopathic pulmonary fibrosis: A genetic disease that involves mucociliary dysfunction of the peripheral airways. Physiol. Rev., 2016, 96(4), 1567-1591.
[http://dx.doi.org/10.1152/physrev.00004.2016] [PMID: 27630174]
[55]
Selman, M.; Carrillo, G.; Estrada, A.; Mejia, M.; Becerril, C.; Cisneros, J.; Gaxiola, M.; Pérez-Padilla, R.; Navarro, C.; Richards, T.; Dauber, J.; King, T.E., Jr; Pardo, A.; Kaminski, N. Accelerated variant of idiopathic pulmonary fibrosis: Clinical behavior and gene expression pattern. PLoS One, 2007, 2(5), e482.
[http://dx.doi.org/10.1371/journal.pone.0000482] [PMID: 17534432]
[56]
Peljto, A.L.; Zhang, Y.; Fingerlin, T.E.; Ma, S.F.; Garcia, J.G.N.; Richards, T.J.; Silveira, L.J.; Lindell, K.O.; Steele, M.P.; Loyd, J.E.; Gibson, K.F.; Seibold, M.A.; Brown, K.K.; Talbert, J.L.; Markin, C.; Kossen, K.; Seiwert, S.D.; Murphy, E.; Noth, I.; Schwarz, M.I.; Kaminski, N.; Schwartz, D.A. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA, 2013, 309(21), 2232-2239.
[http://dx.doi.org/10.1001/jama.2013.5827] [PMID: 23695349]
[57]
Putman, R.K.; Rosas, I.O.; Hunninghake, G.M. Genetics and early detection in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 2014, 189(7), 770-778.
[http://dx.doi.org/10.1164/rccm.201312-2219PP] [PMID: 24547893]
[58]
Kropski, J.A.; Lawson, W.E.; Young, L.R.; Blackwell, T.S. Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis. Dis. Model. Mech., 2013, 6(1), 9-17.
[http://dx.doi.org/10.1242/dmm.010736] [PMID: 23268535]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy